56428-73-0Relevant academic research and scientific papers
Reactions of p-Coumaric acid with nitrite: Product isolation and mechanism studies
Torres y Torres, Janelle L.,Rosazza, John P. N.
, p. 1486 - 1492 (2001)
p-Coumaric acid (1) is an abundant plant phenolic acid, a dietary chemoprotectant, and an antioxidant. The chemoprotective properties of I were demonstrated in vitro by its reaction with NaNO2 in H2O over a range of pH values. The reaction pathway of I with nitrite is dependent on pH. 4-Hydroxybenzaldehyde (3, 16%), 1′,4-dihydroxybenzeneacetaldehyde oxime (5, 59%), and 4-hydroxy-1′-oxo-benzeneacetaldehyde aldoxime (7, 26%) and 7-hydroxy-1,2(4H)-benzoxazin-4-one (11, 6%) were each formed at pH 2, whereas 4-(2-oxido-1,2,5-oxadiazol-3-yl)phenol (13) was formed at pH 3 (6%) and pH 7 and 10 (both 1%). Products were isolated and characterized by NMR and MS spectral analyses. Formation of benzoxazinone (11) requires the 4-phenolic functional group and the conjugated propenoic acid side chain of p-coumaric acid. The mechanism for nitrosation at pH 2 was examined by reacting I in H218O/NaNO2.
4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads
Ahlert, Heinz,Bhatia, Sanil,Borkhardt, Arndt,Breit, Bernhard,Gunther, Stefan,Hansen, Finn K.,Hugle, Martin,Kraft, Fabian B.,Mishra, Pankaj,Schaker-Hubner, Linda,Schliehe-Diecks, Julian,Scholer, Andrea,Warstat, Robin
, p. 14620 - 14646 (2021/10/20)
Multitarget drugs are an emerging alternative to combination therapies. In three iterative cycles of design, synthesis, and biological evaluation, we developed a novel type of potent hybrid inhibitors of bromodomain, and extra-terminal (BET) proteins and histone deacetylases (HDACs) based on the BET inhibitor XD14 and well-established HDAC inhibitors. The most promising new hybrids, 49 and 61, displayed submicromolar inhibitory activity against HDAC1-3 and 6, and BRD4(1), and possess potent antileukemia activity. 49 induced apoptosis more effectively than the combination of ricolinostat and birabresib (1:1). The most balanced dual inhibitor, 61, induced significantly more apoptosis than the related control compounds 62 (no BRD4(1) affinity) and 63 (no HDAC inhibition) as well as the 1:1 combination of both. Additionally, 61 was well tolerated in an in vivo zebrafish toxicity model. Overall, our data suggest an advantage of dual HDAC/BET inhibitors over the combination of two single targeted compounds.
A deacetylation-diazotation-coupling sequence: Palladium-catalyzed C-C bond formation with acetanilides as formal leaving groups
Schmidt, Bernd,Berger, Rene
supporting information, p. 463 - 476 (2013/05/08)
Acetanilides can be deacetylated and diazotized in situ, and subsequently used in Pd-catalyzed coupling reactions without isolation of the diazonium intermediate. Heck reactions, Suzuki crosscoupling reactions, and a Pd-catalyzed [2+2+1] cycloaddition hav
Mizoroki-heck reactions with 4-phenoldiazonium salts
Schmidt, Bernd,Hoelter, Frank,Berger, Rene,Jessel, Soenke
supporting information; experimental part, p. 2463 - 2473 (2010/12/25)
Significantly better yields were achieved in Mizoroki-Heck reactions using 4-phenoldiazonium salts instead of their O-alkylated analogues under otherwise identical conditions. We found that a one-flask deacetylation-diazotation- precipitation sequence starting from paracetamol or acetanilides derived thereof provides a convenient access to the required diazonium tetrafluoroborates. The utility of these arylating agents in palladium-catalyzed C-C bond forming reactions was demonstrated for a one-flask-synthesis of the heterocyclic core of the drug aripiprazole. Notably, the diazonium salt formation from an acetanilide could be combined with two Pd-catalyzed steps in a one-flask sequence, without any exchange of solvents or isolation of intermediates.
